Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROMIDEPSIN for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 30 adverse event reports in the FDA FAERS database where ROMIDEPSIN was used for Lymphoma.

Most Reported Side Effects for ROMIDEPSIN

Side Effect Reports % Deaths Hosp.
Peripheral t-cell lymphoma unspecified 102 8.0% 73 18
Nausea 91 7.1% 11 33
Death 90 7.0% 90 10
Thrombocytopenia 90 7.0% 23 29
Pyrexia 77 6.0% 18 49
Drug ineffective 69 5.4% 19 25
Anaemia 61 4.8% 14 21
Electrocardiogram qt prolonged 61 4.8% 5 3
Platelet count decreased 60 4.7% 22 24
Vomiting 57 4.5% 5 28
Fatigue 55 4.3% 7 21
Product storage error 53 4.1% 0 0
Atrial fibrillation 52 4.1% 9 23
Neutropenia 49 3.8% 9 10
Malignant neoplasm progression 45 3.5% 17 8

Other Indications for ROMIDEPSIN

Peripheral t-cell lymphoma unspecified (390) Product used for unknown indication (171) Angioimmunoblastic t-cell lymphoma (140) Cutaneous t-cell lymphoma (101) T-cell lymphoma (81) Mycosis fungoides (48) Breast cancer metastatic (37) Acute myeloid leukaemia (29) Adult t-cell lymphoma/leukaemia (20) Neoplasm malignant (16)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

ROMIDEPSIN Full Profile All Lymphoma Drugs ROMIDEPSIN Demographics ROMIDEPSIN Timeline